Hormonal contraceptive users' self-reported benefits, adverse reactions, and fears in 2001 and 2007
- PMID: 22272924
- DOI: 10.2165/1312067-200801030-00004
Hormonal contraceptive users' self-reported benefits, adverse reactions, and fears in 2001 and 2007
Abstract
Background: Hormonal contraceptives (HCs) are the most common contraceptive method in western countries. The fears and problems experienced by users of HCs can have an impact on their quality of life, and lead to abortions and unwanted pregnancies.
Objective: To investigate whether experiences and perceptions of HC users in Finland have changed from 2001 to 2007.
Methods: Data were collected using questionnaire surveys of women using HCs in 2001 and 2007. In Finland, HCs are available with a physician's prescription, and are only supplied in community and university pharmacies. University pharmacies in 12 large cities across Finland were selected to distribute the questionnaires. The response rate was 53% (n = 264) in 2001 and 55% (n = 436) in 2007. The average age of the respondents was 26 years in both surveys. The surveys measured self-reported benefits and adverse reactions, preconceptions, fears, knowledge, and opinions.
Results: The number of HC users reporting fears increased from 2001 to 2007 (p = 0.002), whereas the number of HC users reporting adverse reactions decreased (p = 0.013). In both surveys, the most common fear was infertility after HC use (17% vs 26% for 2001 and 2007, respectively). In both surveys, the most common benefits were efficacy and regular menstrual cycle, and the most common adverse reactions were mood swings, lowered libido, and weight gain.
Conclusions: Our study suggests that, although women using HCs were convinced about their benefits, and the number of users reporting adverse reactions had decreased from 2001 to 2007, the number of users reporting fears had increased. Healthcare professionals need to provide counseling in order to alleviate women's fears and to correct false perceptions of HCs.
Similar articles
-
Information sources used by women in Finland who use hormonal contraceptives.Pharm World Sci. 2010 Feb;32(1):66-72. doi: 10.1007/s11096-009-9344-6. Epub 2009 Oct 30. Pharm World Sci. 2010. PMID: 19876757
-
Menopausal hormone therapy--benefits, adverse reactions, concerns and information sources in 2009.Maturitas. 2011 Sep;70(1):69-73. doi: 10.1016/j.maturitas.2011.06.001. Epub 2011 Jul 1. Maturitas. 2011. PMID: 21723053
-
An audit of hormonal contraceptive use in Women's Super League soccer players; implications on symptomology.Sci Med Footb. 2022 May;6(2):153-158. doi: 10.1080/24733938.2021.1921248. Epub 2021 May 16. Sci Med Footb. 2022. PMID: 35475746
-
Medical aspects of oral contraceptive discontinuation.Adv Contracept. 1992 Oct;8 Suppl 1:21-33. doi: 10.1007/BF01849448. Adv Contracept. 1992. PMID: 1442247 Review.
-
Contraception and women's health.Br Med Bull. 1993 Jan;49(1):245-51. doi: 10.1093/oxfordjournals.bmb.a072602. Br Med Bull. 1993. PMID: 8324613 Review.
Cited by
-
Information sources used by women in Finland who use hormonal contraceptives.Pharm World Sci. 2010 Feb;32(1):66-72. doi: 10.1007/s11096-009-9344-6. Epub 2009 Oct 30. Pharm World Sci. 2010. PMID: 19876757
-
The Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept.J Sex Res. 2016 May-Jun;53(4-5):417-56. doi: 10.1080/00224499.2015.1134425. Epub 2016 Mar 8. J Sex Res. 2016. PMID: 26954608 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources